Relapsed Follicular Lymphoma

Oncology·MeSH: Lymphoma, Large B-Cell, Diffuse

Prevalence

56.0 / 100K

Incidence

19.6 / 100K/yr

0 drugs in development·0 companies·2 clinical trials

Frequently asked questions

How many clinical trials target Relapsed Follicular Lymphoma?

There are 2 clinical trials targeting Relapsed Follicular Lymphoma tracked by BioSniper.

What is the prevalence of Relapsed Follicular Lymphoma?

The estimated prevalence of Relapsed Follicular Lymphoma is approximately 56.0 per 100,000 population.

Deep-dive into Relapsed Follicular Lymphoma

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Relapsed Follicular Lymphoma — Drugs in Development & Clinical Trials | BioSniper